6-52024560-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_138694.4(PKHD1):c.5236+14A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0295 in 1,612,358 control chromosomes in the GnomAD database, including 1,005 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 59 hom., cov: 32)
Exomes 𝑓: 0.030 ( 946 hom. )
Consequence
PKHD1
NM_138694.4 intron
NM_138694.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.160
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-52024560-T-C is Benign according to our data. Variant chr6-52024560-T-C is described in ClinVar as [Benign]. Clinvar id is 96405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-52024560-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0778 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKHD1 | NM_138694.4 | c.5236+14A>G | intron_variant | ENST00000371117.8 | NP_619639.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKHD1 | ENST00000371117.8 | c.5236+14A>G | intron_variant | 1 | NM_138694.4 | ENSP00000360158 | P2 | |||
PKHD1 | ENST00000340994.4 | c.5236+14A>G | intron_variant | 5 | ENSP00000341097 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0212 AC: 3225AN: 152172Hom.: 59 Cov.: 32
GnomAD3 genomes
AF:
AC:
3225
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0290 AC: 7243AN: 249568Hom.: 181 AF XY: 0.0323 AC XY: 4375AN XY: 135330
GnomAD3 exomes
AF:
AC:
7243
AN:
249568
Hom.:
AF XY:
AC XY:
4375
AN XY:
135330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0304 AC: 44348AN: 1460068Hom.: 946 Cov.: 32 AF XY: 0.0320 AC XY: 23263AN XY: 726480
GnomAD4 exome
AF:
AC:
44348
AN:
1460068
Hom.:
Cov.:
32
AF XY:
AC XY:
23263
AN XY:
726480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0212 AC: 3229AN: 152290Hom.: 59 Cov.: 32 AF XY: 0.0216 AC XY: 1609AN XY: 74460
GnomAD4 genome
AF:
AC:
3229
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
1609
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
135
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 04, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Autosomal recessive polycystic kidney disease Benign:4
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 13, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Counsyl | Apr 26, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Polycystic kidney disease Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKHD1 c.5236+14A>G variant was identified as a polymorphism both in proband and control chromosomes at a frequency: 0.05 (Bergmann 2005 , Losekoot 2005 , Sharp 2005 ). The variant was also identified in dbSNP (ID: rs12210725) “With Benign allele”, with a minor allele frequency of 0.0228 (114 of 5000 chromosomes) 1000 Genomes Project; HAPMAP-CEU in 4 of 120 chromosomes (frequency: 0.3333); HAPMAP-HCB in 2 of 90 chromosomes (frequency: 0.02222); NHLBI GO Exome Sequencing Project in 281 of 8600 European American (freq. 0.0327) and 21 of 4406 (freq. 0.004766) African American chromosomes; Exome Aggregation Consortium database (March 14, 2016) in 3671 (93 homozygous) of 117172 chromosomes (freq. 0.03133) in the following populations: South Asian in 1393 of 16478 chromosomes (freq. 0.08454), European (Non-Finnish) in 1975 of 64092 chromosomes (freq. 0.03082), Latino in 136 of 11480 chromosomes (freq. 0.01185), European (Finnish) in 54 of 6600 chromosomes (freq. 0.008182), and African in 45 of 9138 chromosomes (freq. 0.004924), East Asian in 42 of 8498 (freq. 0.004942) and Other populations in 26 of 886 (freq. 0.02935), indicating the variant a benign polymorphism; Clinvitae (benign by EmyClass); the ClinVar (benign by Emory Genetics), GeneInsight COGR (benign by LMM); RWTH AAachen University ARPKD database (polymorphism). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict the abolishment of the consensus splice site but predict creation of a new 5' splice site in this region. This information is not very predictive of pathogenicity. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 10, 2018 | - - |
Polycystic kidney disease 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Pars Genome Lab | Jun 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at